Xu Jin-shui, Wang Bei, Wang Chang-xian, Gou Hai-jian, Mi Zu-huang, Ling Jian-hua
Department of Epidemiology, Public Health School of Southeast University, Nanjing 210009, China.
Zhonghua Liu Xing Bing Xue Za Zhi. 2006 Aug;27(8):702-4.
To study the phenotypic and genotypic resistance to Fluoroquinolones in Neisseria gonorrhoeae (NG) isolated in Jiangsu province of China.
In-vitro, susceptibility testing of ciprofloxacin and levofloxacin against ninety-five clinical isolates were determined by agar dilution method. Detection of mutation in the gyrA and parC genes was performed by polymerase chain reaction (PCR) assay and sequence analysis.
The clinical isolates demonstrated 100% resistance to ciprofloxacin. Based on gyrA and parC mutations, 18 types could be categorized among the 54 isolates. Based on the same gyrA mutations,isolates with high MIC appeared to have had more mutations in parC gene.
The status of resistance to ciprofloxacin in NG was quite serious, and ciprofloxacin treatment for the treatment of NG infections in Jiangsu province should not be recommended. The results from this study suggested that mutations in the parC gene had contributed to the development of high Fluoroquinolone resistance in NG.
研究中国江苏省分离的淋病奈瑟菌(NG)对氟喹诺酮类药物的表型和基因型耐药情况。
采用琼脂稀释法对95株临床分离株进行环丙沙星和左氧氟沙星的体外药敏试验。通过聚合酶链反应(PCR)检测和序列分析对gyrA和parC基因的突变进行检测。
临床分离株对环丙沙星的耐药率为100%。根据gyrA和parC基因突变情况,54株分离株可分为18种类型。基于相同的gyrA基因突变,高最低抑菌浓度(MIC)的分离株在parC基因上似乎有更多突变。
NG对环丙沙星的耐药情况相当严重,不建议在江苏省使用环丙沙星治疗NG感染。本研究结果表明,parC基因突变促成了NG对氟喹诺酮类药物的高度耐药。